Start up, 10X Genomics, to start offering long-read solution leveraging existing Illumina technology.
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
23andMe & Genentech partner to find new therapeutic targets for Parkinson’s
Claritas Genomics have selected NextCODE Health to help improve their genomic capabilities…..
llumina announce their three picks for inaugural Illumina Accelerator funding cycle.
User-friendly analytical tools could be set to help make genomic analysis much more widespread.